| |
|
|
|
Seres Theraptc  
|
|
26.36 1.11 (0.04%) |
09-25 16:00 |
|
Open: |
25.25 |
Pre close: |
25.25 |
Target:
|
33.07
|
|
High: |
26.49 |
Low: |
25.03 |
Resistance:
|
28.31
33.07
|
|
Volume: |
586,717 |
Market Cap: |
2354M |
Support:
|
24.43
22.03
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
25.97
 |
MACD |
MACD(12,26):
|
1.74  |
|
MA(20): |
25.67 |
Signal(12,26,9): |
2.30 |
|
MA(100): |
11.71 |
Stochastic Oscillator |
%K(14,3):
|
58.33 |
|
MA(250): |
6.81 |
%D(3): |
60.60 |
|
Average Volume(K) |
3-Month: |
312071
|
52-Week |
High:
|
33.00 |
|
10-Days: |
75253 |
Low: |
2.52 |
|
RSI |
RSI(14):
|
61.06 |
Change(%): |
557.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.070 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
89.29 |
|
EPS Est. Current Year |
-2.510 |
Return on Assets (ttm) |
-38.8 |
Shares Float (M) |
50.71 |
|
EPS Est. Next Year |
-2.860 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.00 |
|
EPS Est. Next Quarter |
-0.780 |
Qtrly Rev. Growth |
-51.8 |
% Held by Institutions |
80.15 |
|
Forward EPS |
-1.240 |
Gross Profit (p.s.) |
-0.511 |
Shares Short (K) |
5240 |
|
Book Value (p.s.) |
-0.870 |
EBITDA (p.s.) |
-0.778 |
P/E |
-24.64 |
|
Sales Per Share |
0.324 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-30.30 |
|
Profit Margin |
-262.34 |
Operating Cash Flow
(M) |
-82.16 |
P/S |
81.47 |
|
Operating Margin |
-265.21 |
Levered Free Cash Flow
(M) |
-35.70 |
P/CF |
-28.65 |
|
|
|
|
|
|
